While the FDA issued alerts and marketing materials for consumers to understand mandated changes to how Nutrition Facts panels will look, no such effort was done for changes in the Supplement Facts panel, so one trade group took the lead.
The nootropic category is again under that microscope as the Federal Trade Commission has announced the settlement of a case over unsupported cognitive support claims that generated a combined $26 million in fines.
By Michael McGuffin, president, American Herbal Products Association
Looking back 25 years, there are several remarkable aspects of the Dietary Supplement Health and Education Act (DSHEA) amendments to the Food Drug and Cosmetic Act (FD&C Act), which transformed how dietary supplements are regulated.
The US Food and Drug Administration issued 11 warning letters yesterday to companies that have non NDI ingredients in their products. Eight of the warning letters concerned DMHA, with the other three concerned phenibut.
The Food and Drug Administration announced a new ‘rapid communication tool,’ called the Dietary Ingredient Advisory List. Trade groups and industry experts applauded the effort, but many opined that this step still has much left to be desired in terms...
The brilliant strategy of Sen. Orrin Hatch, the upswell of grassroots consumer pressure, and the ‘highly unusual’ personal intervention of an FDA Commissioner: The development and passage of the Dietary Supplement Health and Education Act is a fascinating...
As talk in the industry and at the FDA continues around the modernization of DSHEA, not everyone thinks big changes are needed. “The best thing the Agency does is inspect and test,” says NPA’s Dr Daniel Fabricant.
The European Food Safety Authority (EFSA)’s approval of additional uses of betaine comes with a caveat as the Agency warns sportspeople taking supplements containing the amino acid may exceed safe levels.
Should the creation of a new herbal medicine category be one of the goals of the upcoming discussions about a new regulatory framework? If it were possible, such a change could clear up many of the ambiguities surrounding the marketing of these products...
A leading vitamin K2 developer is working to establish a global K2-specific recommended daily intake as part of its heavyweight awareness campaign targeting health professionals, legislators and consumers.
With scientific advances and the growth of the dietary supplements industry on one hand, and the proliferation of adulterated and misbranded products on the other, the opportunity to modernize DSHEA couldn’t come at a better time.